Knoll Capital Management, LLC Avadel Pharmaceuticals PLC Transaction History
Knoll Capital Management, LLC
- $147 Million
- Q2 2025
A detailed history of Knoll Capital Management, LLC transactions in Avadel Pharmaceuticals PLC stock. As of the latest transaction made, Knoll Capital Management, LLC holds 600,000 shares of AVDL stock, worth $8.04 Million. This represents 3.61% of its overall portfolio holdings.
Number of Shares
600,000
Previous 600,000
-0.0%
Holding current value
$8.04 Million
Previous $4.7 Million
13.03%
% of portfolio
3.61%
Previous 3.14%
Shares
3 transactions
Others Institutions Holding AVDL
# of Institutions
7Shares Held
738KCall Options Held
25KPut Options Held
0-
Schulhoff & CO Inc138KShares$1.84 Million0.58% of portfolio
-
American Portfolios Advisors Holbrook, NY500Shares$6,7000.0% of portfolio
-
American Research & Management Co.100Shares$1,3400.0% of portfolio
-
Exane Derivatives33Shares$4420.0% of portfolio
-
Huntington National Bank Columbus, OH1Shares$130.0% of portfolio
About AVADEL PHARMACEUTICALS PLC
- Ticker AVDL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 60,581,300
- Market Cap $812M
- Description
- Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Its lead product candidate is FT218, a formulation of sodium oxybate, which is in a Phase 3 clinical trial for the treatment of excessive daytime sleepiness and cataplexy in adults with narcolepsy. The company was formerly known as Flamel Technologies SA and...